The patient was administered a
fibrinolytic drug to dissolve the blood clot in their leg.
病人被给予纤维蛋白溶解药以溶解腿部的血栓。
Fibrinolytic therapy is often the first line of treatment for heart attacks, as it helps break down clots in冠状动脉.
纤维蛋白溶解疗法常常是心脏病发作的一线治疗,因为它有助于分解冠状动脉内的血栓。
A
fibrinolytic agent was used to prevent excessive blood clotting during surgery.
手术中使用了纤维蛋白溶解剂来防止血液过度凝固。
The doctor decided against using a
fibrinolytic because the patient's risk of bleeding was too high.
医生决定不使用纤维蛋白溶解剂,因为患者的出血风险过高。
Fibrinolytic therapy can be dangerous if not administered properly, as it can cause severe bleeding complications.
如果使用不当,纤维蛋白溶解疗法可能会带来严重的出血并发症。
In stroke patients, administering a
fibrinolytic can help restore blood flow to the brain before permanent damage occurs.
对于中风患者,及时给予纤维蛋白溶解剂可以恢复大脑的血流,防止永久性损伤。
The researchers are studying new, more targeted
fibrinolytic drugs to improve treatment outcomes for patients with deep vein thrombosis.
研究人员正在研究新的、更精确的纤维蛋白溶解药物,以改善深静脉血栓患者的治疗效果。
Fibrinolytic medications work by breaking down fibrin, a protein that forms clots in the blood.
纤维蛋白溶解药物通过分解血液中的纤维蛋白(形成血栓的蛋白质)来发挥作用。
Emergency medical personnel must carefully assess the appropriateness of
fibrinolytic use before administering it in an acute cardiac event.
急救人员在给急性心脏事件患者使用纤维蛋白溶解剂前,必须仔细评估其适用性。
Post-operative care often includes monitoring for signs of excessive fibrinolysis, such as increased bleeding or bruising.
术后护理通常包括监测过量纤维蛋白溶解的迹象,如出血或瘀伤增加。
未经许可,严禁转发。QQ交流群:688169419